EE04036B1 - Kompositsioon alkoholi abstinentsisündroomi ja alkoholihimu mahasurumiseks alkohoolikutel ning alkoholi kuritarvitamise vältimiseks tervetel inimestel - Google Patents

Kompositsioon alkoholi abstinentsisündroomi ja alkoholihimu mahasurumiseks alkohoolikutel ning alkoholi kuritarvitamise vältimiseks tervetel inimestel

Info

Publication number
EE04036B1
EE04036B1 EEP200000235A EEP200000235A EE04036B1 EE 04036 B1 EE04036 B1 EE 04036B1 EE P200000235 A EEP200000235 A EE P200000235A EE P200000235 A EEP200000235 A EE P200000235A EE 04036 B1 EE04036 B1 EE 04036B1
Authority
EE
Estonia
Prior art keywords
alcohol
alcoholics
composition
craving
preventing
Prior art date
Application number
EEP200000235A
Other languages
English (en)
Inventor
Fassi Aldo
Cavazza Claudio
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of EE200000235A publication Critical patent/EE200000235A/et
Publication of EE04036B1 publication Critical patent/EE04036B1/et

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Addiction (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
EEP200000235A 1997-10-03 1998-09-18 Kompositsioon alkoholi abstinentsisündroomi ja alkoholihimu mahasurumiseks alkohoolikutel ning alkoholi kuritarvitamise vältimiseks tervetel inimestel EE04036B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97RM000594A IT1295408B1 (it) 1997-10-03 1997-10-03 Associazione di l-carnitina e alcanoil l-carnitine per il trattamento dell'alcoolismo
PCT/IT1998/000249 WO1999017623A1 (en) 1997-10-03 1998-09-18 Composition for suppressing withdrawal symptoms and craving for alcohol in alcoholics and preventing the abuse of alcohol in healthy subjects

Publications (2)

Publication Number Publication Date
EE200000235A EE200000235A (et) 2001-06-15
EE04036B1 true EE04036B1 (et) 2003-06-16

Family

ID=11405277

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000235A EE04036B1 (et) 1997-10-03 1998-09-18 Kompositsioon alkoholi abstinentsisündroomi ja alkoholihimu mahasurumiseks alkohoolikutel ning alkoholi kuritarvitamise vältimiseks tervetel inimestel

Country Status (28)

Country Link
US (1) US6255346B1 (et)
EP (1) EP1022960B1 (et)
JP (1) JP2001518484A (et)
KR (2) KR100530368B1 (et)
CN (1) CN1092939C (et)
AT (1) ATE220860T1 (et)
AU (1) AU730740B2 (et)
BG (1) BG64363B1 (et)
BR (1) BR9812604A (et)
CA (1) CA2305598C (et)
CZ (1) CZ291801B6 (et)
DE (1) DE69806788T2 (et)
DK (1) DK1022960T3 (et)
EA (1) EA002177B1 (et)
EE (1) EE04036B1 (et)
ES (1) ES2180200T3 (et)
HK (1) HK1028714A1 (et)
HU (1) HUP0004336A3 (et)
IS (1) IS2234B (et)
IT (1) IT1295408B1 (et)
MX (1) MXPA00003232A (et)
NO (1) NO20001688L (et)
NZ (1) NZ503663A (et)
PL (1) PL189663B1 (et)
PT (1) PT1022960E (et)
SK (1) SK283384B6 (et)
UA (1) UA66807C2 (et)
WO (1) WO1999017623A1 (et)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
IT1306179B1 (it) 1999-07-28 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
ITRM20020194A1 (it) 2002-04-09 2003-10-09 Sigma Tau Healthscience Spa Composizione utile per aumentare la concentrazione e la motilita' degli spermatozoi e migliorarne la morfologia nell'uomo.
US7776913B2 (en) 2002-12-13 2010-08-17 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Carnitines for treating or preventing disorders caused by andropause
ITRM20020620A1 (it) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.
CN101766637B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN101766716B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN101766717B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN101766672B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN101766715B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN101766635B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN106176756A (zh) * 2015-04-30 2016-12-07 刘力 包含手性异构化合物的赖氨酸五维药物组合物及其用途
WO2021211540A1 (en) * 2020-04-14 2021-10-21 The Regents Of The University Of California Diagnosis and treatment of addiction

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245869B (it) * 1991-06-05 1994-10-25 Sigma Tau Ind Farmaceuti Impiego di propionil l-carnitina per il recupero del tono muscolare in soggetti immobilizzati
DE19527281A1 (de) * 1995-07-26 1997-01-30 Hans Guenter Berner Gmbh Nahrungsergänzungsmittel
DE69618749D1 (de) * 1995-12-01 2002-03-14 Unilever Nv Mikrowellen erhitzbare knusperige Brötchen
ATE187329T1 (de) * 1996-03-04 1999-12-15 Sigma Tau Ind Farmaceuti Carnitinderivat als arzneimittel zur behandlung von arteriosklerose obliterans

Also Published As

Publication number Publication date
SK4762000A3 (en) 2000-10-09
SK283384B6 (sk) 2003-06-03
PL189663B1 (pl) 2005-09-30
NO20001688L (no) 2000-06-02
KR100560097B1 (ko) 2006-03-13
JP2001518484A (ja) 2001-10-16
AU730740B2 (en) 2001-03-15
EP1022960B1 (en) 2002-07-24
DE69806788T2 (de) 2003-04-03
CN1092939C (zh) 2002-10-23
KR20050088499A (ko) 2005-09-06
ES2180200T3 (es) 2003-02-01
UA66807C2 (uk) 2004-06-15
HUP0004336A3 (en) 2001-07-30
BR9812604A (pt) 2000-08-01
IT1295408B1 (it) 1999-05-12
IS2234B (is) 2007-04-15
CN1276704A (zh) 2000-12-13
PT1022960E (pt) 2002-12-31
DE69806788D1 (de) 2002-08-29
ATE220860T1 (de) 2002-08-15
CZ20001207A3 (cs) 2000-11-15
AU9366098A (en) 1999-04-27
HK1028714A1 (en) 2001-03-02
BG64363B1 (bg) 2004-12-30
NZ503663A (en) 2001-11-30
NO20001688D0 (no) 2000-03-31
EP1022960A1 (en) 2000-08-02
IS5416A (is) 2000-03-24
CA2305598A1 (en) 1999-04-15
KR100530368B1 (ko) 2005-11-22
WO1999017623A1 (en) 1999-04-15
PL339621A1 (en) 2001-01-02
EA002177B1 (ru) 2002-02-28
EA200000377A1 (ru) 2000-10-30
CZ291801B6 (cs) 2003-05-14
KR20010030928A (ko) 2001-04-16
CA2305598C (en) 2007-11-20
HUP0004336A2 (hu) 2001-05-28
ITRM970594A1 (it) 1999-04-03
DK1022960T3 (da) 2002-11-04
EE200000235A (et) 2001-06-15
MXPA00003232A (es) 2004-03-10
US6255346B1 (en) 2001-07-03
BG104286A (en) 2000-11-30

Similar Documents

Publication Publication Date Title
EE200000235A (et) Kompositsioon alkoholi abstinentsisündroomi ja alkoholihimu mahasurumiseks alkohoolikutel ning alkoholi kuritarvitamise vältimiseks tervetel inimestel
WO2003013549A3 (de) Formulierung enthaltend (lyso-) phosphatidylserin zur vorbeugung und behandlung von stresszuständen bei warmblütern
BR9815302A (pt) Método para diminuir a concentração de colesterol ldl e aumentar a concentração de colesterol hdl no sangue para reduzir o risco de aterosclerose e doença vascular
WO2001062290A3 (en) Methods and compositions for improving sleep
BR9711054A (pt) Composições de carbohidratos de plantas como suplementos dietéticos.
CA2294099A1 (en) Absorption of minerals
PT1337236E (pt) Suplemento a ser administrado entericamente para alimentacao parenterica ou paraalimentacao parcial enterica/ oral de doentes em estado critico, doentes cronicos e de pessoas mal nutridas
WO2001026666A3 (en) Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba
DE69721497D1 (de) Multifunktionelle formulierung für fettabsorbierung und zur senkung des cholesterolgehaltes im blut, welche chitosan und nicotinsäure enthält
WO2002072035A3 (en) Novel anti-inflammatory compositions and methods of use
JP4706174B2 (ja) α−グルコシダーゼ阻害剤
RU95119282A (ru) Композиция ингредиентов для лекарственного средства
Cerrato Ginseng doesn't improve one's mood
Joseph A contemporary narrative review on Oral Submucous Fibrosis
CA2325033A1 (en) Use of ribose to treat fibromyalgia
EP0778027A3 (de) Verwendung von Kieselerde zur Herstellung von Arzneimitteln
Thomas et al. Scurvy in a nonalcoholic person in the United States
Kirvelä et al. Lipid based parenteral nutrition in cystic fibrosis
ES2134865T3 (es) Uso de extracto de orujo de cerveza para la fabricacion de preparados de administracion oral.
Hébuteme et al. Effects of nutritional therapy on lipid metabolism in the intestinal mucosa
Wang et al. Patient-doctor relationship in option to SARS
Trivedi et al. Reversible Impairment of Glucose Tolerance in Patients with Endemic Fluorosis
KR970032880A (ko) 산사와 당근의 추출물을 함유하는 동맥경화 예방 및 완화용 조성물
So Scurvy in an urban dweller in Hong Kong
Wenzheng Study on metabolites of scutellarin in gastrointestinal tract by UPLC-MS/MS method

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20080918